Letters Section Editor: Stephen J. Lurie,
MD, PhD, Senior Editor.
To the Editor: In their Contempo Updates article
about treating age-related cataracts, Drs Solomon and Donnenfeld1 provided
no evidence to support their assertion that, "Postoperatively, a patient is
often started on topical eye drops, antibiotics to prevent infection (fourth-generation
fluoroquinolones [gatifloxacin or moxifloxacin]), . . . ." Although topical
antibiotics are part of the typical regimen to prevent postoperative infections
in patients receiving cataract surgery, the newest addition to our antibiotic
arsenal, topical fourth-generation fluoroquinolones, have not been shown in
controlled studies to be better than existing agents.
Sauer S. Topical Antibiotics Before Cataract Surgery. JAMA. 2003;290(22):2937-2938. doi:10.1001/jama.290.22.2937-a